Translational Hemorrhagic Stroke: Physiology, Pharmaceutical Drugs, and Management
نویسندگان
چکیده
1Departments of Neurosurgery, Physiology, and Anesthesiology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA 2Department of Neurosurgery, University of Cincinnati, Cincinnati, OH 45219, USA 3Department of Neurosurgery, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland 4Department of Neurosurgery, Soochow University, Jiangsu, China 5Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China
منابع مشابه
The Evaluation and Comparison of Oxidative Stress in Hemorrhagic and Ischemic Stroke
Background: Among different mechanisms, oxidative stress has a possible role in neural injury in cerebrovascular events. Objectives: Assessment the oxidants-antioxidants imbalance in ischemic and hemorrhagic strokes. Materials and Methods: Serum level of malondialdehyde, the main marker of lipid peroxidation, and total antioxidant capacity were measured in a group of 48 stroke patients consis...
متن کاملCoarse Tremor as the Only Sign of Perinatal Hemorrhagic Stroke: A Case Report
Background: Tremor which is the most common abnormal movement in the neonatal period might be a benign condition or the result of pathologic events and is divided into two subtypes, namely fine tremor and coarse tremor. Fine tremor is usually benign and results from some metabolic disturbance, such as hypoglycemia. On the other hand, coarse tremor is an indicator of brain insult and should be r...
متن کاملTranslational medicine for stroke drug discovery: the pharmaceutical industry perspective.
Over the past 20 years, an estimated $1 billion has been spent in research and development of stroke therapeutics; however, this huge investment has failed to produce a clinically efficacious drug with the exception of the thrombolytic agent Activase (tPA). This sobering reality has been the subject of numerous reflections by renowned leaders in stroke research with special focus on the most re...
متن کاملNeuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke
Stroke is a leading cause of disability and death, yet effective treatments for acute stroke has been very limited. Thus far, tissue plasminogen activator has been the only FDA-approved drug for thrombolytic treatment of ischemic stroke patients, yet its application is only applicable to less than 4-5% of stroke patients due to the narrow therapeutic window (< 4.5 hours after the onset of strok...
متن کاملAssociation of serum magnesium levels with risk factors, severity and prognosis in ischemic and hemorrhagic stroke patients
Background: Stroke is the third leading cause of mortality worldwide. One of the factors that affect the occurrence of stroke can be attributed to changes in the levels of trace elements. Accumulating evidence has been shown that magnesium, as an important element, is a new predictor of stroke. We aimed to determine the levels of Mg in ischemic stroke patients in comparison with those having th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 2017 شماره
صفحات -
تاریخ انتشار 2017